BI
BIMI.US Bimi International Medical Inc
- Market cap
- USD 1.40K
- P/E
- -
- P/B
- 0.00x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Is BIMI.US undervalued?
Graham numberThe Graham number of Bimi International Medical Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Bimi International Medical Inc fundamental analysis
No fundamental analysis for Bimi International Medical Inc yet.
Bimi International Medical Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Bimi International Medical Inc
BIMI Holdings Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical solution, and pharmaceutical and other healthcare products in the People's Republic of China and the United States. The company operates through four segments: Medical Devices; Healthcare Products; Wholesale Pharmaceuticals; and Pharmacy Retail. The Pharmacy Retail segment offers prescription and OTC medicines; TCM; healthcare supplies; traditional Chinese medicine…
Full company profileBimi International Medical Inc financial statements
Bimi International Medical Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 9.98M | 6.72M | 6.04M | 8.51M | 6.54M | 158K | 12.8M | 21.3M | 11.8M | 12.6M |
| Gross Profit | 1.48M | 1.18M | 149K | 917K | 459K | -146K | 2.44M | 2.43M | 1.95M | 5.09M |
| Operating Income | -376K | -641K | -1.48M | -1.20M | -15.8M | -986K | -3.81M | -8.11M | -15.3M | -3.82M |
| EBITDA | 713K | 663K | -465K | -278K | -14.8M | -1.27M | -3.21M | -32.0M | -18.0M | - |
| Net Income | -617K | -969K | -1.82M | -1.57M | -16.8M | -4.44M | -5.29M | -35.0M | -22.4M | -10.5M |
| EPS | -5.44 | -7.73 | -14 | -11 | -2.22 | -27 | -25 | -65 | -8.40 | - |
| Balance Sheet | ||||||||||
| Total Assets | 48.3M | 44.4M | 37.3M | 41.4M | 23.1M | 30.1M | 33.2M | 38.1M | 35.7M | - |
| Total Liabilities | 17.0M | 14.0M | 10.6M | 14.1M | 13.1M | 21.5M | 16.3M | 26.8M | 30.5M | - |
| Shareholders' Equity | 31.3M | 30.4M | 26.7M | 27.2M | 9.99M | 8.68M | 16.7M | 11.2M | 4.05M | - |
| Cash & Short-term Investments | 1.30M | 435K | 125K | 282K | 197K | 36.4K | 135K | 4.61M | 2.34M | - |
| Total Debt | 9.95M | 8.06M | 5.76M | 7.22M | 5.82M | 107K | 5.03M | 8.73M | 5.46M | - |
| Cash Flow | ||||||||||
| Operating Cash Flow | -995K | -2.47M | 160K | -908K | -344K | -2.06M | -3.52M | -1.28M | -10.3M | -2.90M |
| Capital Expenditure | 342K | 663K | 408K | 259K | 259K | 259K | 259K | 815K | 0.00 | 0.00 |
| Free Cash Flow | -1.34M | -3.14M | -248K | -908K | -344K | -2.06M | -3.78M | -2.09M | -10.3M | -3.50M |
| Ratios | ||||||||||
| ROE | -2.0% | -3.2% | -6.8% | -5.8% | -168.1% | -51.1% | -31.7% | -312.6% | -553.2% | - |
| ROA | -1.3% | -2.2% | -4.9% | -3.8% | -72.8% | -14.8% | -15.9% | -91.8% | -62.7% | - |
| Net Profit Margin | -6.2% | -14.4% | -30.1% | -18.5% | -256.6% | -2,809.9% | -41.2% | -164.1% | -189.3% | -83.2% |
| Debt to Equity | 0.32x | 0.27x | 0.22x | 0.27x | 0.58x | 0.01x | 0.30x | 0.78x | 1.35x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Bimi International Medical Inc dividends
Bimi International Medical Inc has not paid dividends in the last 10 fiscal years.
Last stock split: 1:10 on Dec 12, 2022.
Who owns Bimi International Medical Inc
Top funds holding BIMI.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Muamalat Invest Islamic Equity Fund | 30.0K | 0.21% | 0.00% | Dec 2025 |
Top institutions holding BIMI.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| XTX Topco Ltd | 0.00 | 0.00% | -100.00% | Dec 2024 |
Bimi International Medical Inc company profile
- Company name
- Bimi International Medical Inc
- Ticker
- BIMI.US
- Exchange
- USA Stocks
- Listed since
- Oct 18, 2006
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 296
- Fiscal year end
- December
- Address
- 725 5th Avenue, New York, NY, United States, 10022
- Phone
- 212 542 0028
- Website
- usbimi.com
About Bimi International Medical Inc
BIMI Holdings Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical solution, and pharmaceutical and other healthcare products in the People's Republic of China and the United States. The company operates through four segments: Medical Devices; Healthcare Products; Wholesale Pharmaceuticals; and Pharmacy Retail. The Pharmacy Retail segment offers prescription and OTC medicines; TCM; healthcare supplies; traditional Chinese medicines; and sundry items. The Wholesale Pharmaceuticals segment provides prescription; OTC medicines; TCM; healthcare supplies; and sundry items. The Medical Device segment distributes medical devices, including medical consumables. The Healthcare products segment offers dietary supplements comprising cardiovascular products; anti-insomnia and depression products; male aphrodisiac products; menopausal syndrome products; gout products; and immunity products. It sells its products through pharmacies; retail stores; private and government clinics; directly owned stores; third party pharmacies; hospitals; drug wholesalers; and medical device dealers. The company was formerly known as BIMI International Medical Inc. and changed its name to BIMI Holdings Inc. in January 2024. The company was incorporated in 2000 and is based in New York, New York.
Bimi International Medical Inc management
4- Mr. Tiewei SongCEO & Director · born 1972
- Ms. Baiqun ZhongInterim Chief Financial Officer · born 1964
- Mr. Xiaoping WangChief Operating Officer · born 1981
- Mr. Fnu OudomChairman of Board & President · born 1955